The mevalonate pathway, a metabolic target in cancer therapy

B Guerra, C Recio, H Aranda-Tavío… - Frontiers in …, 2021 - frontiersin.org
A hallmark of cancer cells includes a metabolic reprograming that provides energy, the
essential building blocks, and signaling required to maintain survival, rapid growth …

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

T Pillaiyar, S Meenakshisundaram, M Manickam… - European journal of …, 2020 - Elsevier
Drug repurposing is a strategy consisting of finding new indications for already known
marketed drugs used in various clinical settings or highly characterized compounds despite …

Antidiabetics, anthelmintics, statins, and beta-blockers as co-adjuvant drugs in cancer therapy

L Gales, L Forsea, D Mitrea, I Stefanica, I Stanculescu… - Medicina, 2022 - mdpi.com
Over the last years, repurposed agents have provided growing evidence of fast
implementation in oncology treatment such as certain antimalarial, anthelmintic, antibiotics …

High-density lipoproteins: A promising tool against cancer

A Ossoli, A Wolska, AT Remaley… - Biochimica et Biophysica …, 2022 - Elsevier
High-density lipoproteins (HDL) are well known for their protective role against the
development and progression of atherosclerosis. Atheroprotection is mainly due to the key …

Statin use and risk of colorectal cancer in patients with inflammatory bowel disease

J Sun, J Halfvarson, D Bergman, F Ebrahimi… - …, 2023 - thelancet.com
Background Statin use has been linked to a reduced risk of advanced colorectal adenomas,
but its association with colorectal cancer (CRC) in patients with inflammatory bowel disease …

Association between cardiovascular risk factors and colorectal cancer: a systematic review and meta-analysis of prospective cohort studies

C Zhang, Y Cheng, D Luo, J Wang, J Liu, Y Luo… - …, 2021 - thelancet.com
Background Emerging data have suggested colorectal cancer (CRC) often coexists with
cardiovascular diseases, but whether cardiovascular risk factors play a role in CRC remains …

Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance …

D Kim, HJ Kim, HS Ahn - Journal of Cancer Research and Clinical …, 2022 - Springer
Background This study investigated the association between the use of statins, the
incidence of gastric, colorectal, and esophageal cancers, and mortality between January …

The past and future of inflammation as a target to cancer prevention

L Antonucci, M Karin - Cancer Prevention Research, 2024 - AACR
Inflammation is an essential defense mechanism in which innate immune cells are
coordinately activated on encounter of harmful stimuli, including pathogens, tissue injury …

Long-term statin use, total cholesterol level, and risk of colorectal cancer: a prospective cohort study

Y Zhang, K Wu, AT Chan, JA Meyerhardt… - Official journal of the …, 2022 - journals.lww.com
METHODS: Eligible participants (100,300 women and 47,991 men) in the Nurses' Health
Study and Health Professionals Follow-Up Study were followed for up to 24 years. Cox …

Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study

KC Chung, SE Juang, HH Chen, KC Cheng, KL Wu… - BMC …, 2022 - Springer
Abstract Background Metabolic syndrome (MetS) is a worldwide pandemic and complex
disorder associated with colorectal cancer (CRC). This study aims to identify the influence of …